<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

Default sub title

minute read

by HCP Live | February 11, 2026
placeholder

Topics: Press Coverage